A published PFAS method does not prove that every laboratory can reproduce its performance. Differences in analysts, equipment, reagents, background contamination, and sample matrices can affect recovery, precision, and reporting limits.
Before testing routine samples, the laboratory must demonstrate that the complete workflow performs as required. The scale of that study depends on whether the laboratory adopts a published method without significant change or develops and modifies its own procedure.
Distinguish Verification From Validation
Laboratories and accreditation bodies may use the terms differently, but the practical distinction rests on the level of change and uncertainty.
Study | Typical Situation | Central Question |
Verification | The laboratory adopts a recognized method within its stated scope | Can this laboratory meet the method’s required performance? |
Validation | The laboratory develops a method, expands its scope, or makes significant changes | Is the method fit for its intended use? |
Verification confirms performance against established criteria. Validation must establish the criteria and demonstrate that they support the intended application.
A laboratory may need a larger study when it adds analytes, changes extraction procedures, introduces a new matrix, or alters chromatographic conditions beyond the flexibility allowed by the published method.
Define the Intended Use
The study should begin with a written statement of scope. Without one, the laboratory cannot judge whether the results prove enough.
The scope should identify:
- Target PFAS
- Sample matrices
- Measurement range
- Required detection and reporting limits
- Applicable method or regulatory program
- Calibration approach
- Identification criteria
- Expected sample volumes or masses
- Data-quality objectives
This statement also prevents a narrow demonstration in reagent water from becoming unsupported evidence for performance in wastewater, soil, or tissue.
Follow Method-Specific Requirements
Published methods contain their own initial-performance studies. EPA Method 1633A requires laboratories to demonstrate acceptable precision and recovery before analyzing field samples. It provides separate performance criteria for aqueous, solid, biosolid, and tissue matrices.
The method’s initial precision and recovery study uses replicate spiked reference-matrix samples carried through the complete preparation and analytical procedure. The laboratory evaluates mean recovery and relative standard deviation against method criteria.
EPA Method 537.1 includes an initial demonstration of capability for drinking-water analysis. Its requirements also address background contamination, calibration, precision, accuracy, and minimum reporting-level confirmation.
Laboratories should treat these studies as minimum requirements. Additional work may be necessary when the project demands lower reporting limits or includes matrices outside the published scope.
Establish Background Performance
Blank control sits at the centre of PFAS method performance. A laboratory cannot demonstrate low-level capability when its equipment, solvents, or consumables contribute inconsistent target signals.
The study should include enough method, solvent, and instrument blanks to establish typical background and variation over time. A single clean blank does not show that the system remains controlled across preparation days, analysts, and reagent lots.
Blank results should support the proposed reporting limit. When background approaches that limit, the laboratory must remove the source, raise the reporting limit, or define a defensible response consistent with the governing method.
Demonstrate Precision and Recovery
Precision shows whether repeated measurements agree. Recovery shows whether the method measures an appropriate fraction of the amount introduced.
The laboratory should run replicate preparations rather than repeated injections from one vial. Replicate extraction challenges the full workflow, including spiking, handling, cleanup, concentration, and instrumental analysis.
Clean reference matrices establish baseline capability, while matrix spikes test performance in real samples. Both matter. Strong performance in reagent water cannot reveal suppression, extraction resistance, or interference in a complex field matrix.
The study should cover concentrations near the reporting limit and within the routine working range. High-level spikes alone can hide performance problems that dominate trace analysis.
Confirm the Quantitation Limit
A calibration point does not establish a reliable quantitation limit by itself. The complete procedure must produce acceptable identification, precision, and recovery at or near the proposed limit.
EPA’s SW-846 quality-control guidance describes lower-limit verification using a clean control material fortified at the lower limit of quantitation and processed through all preparation and determinative steps.
For PFAS methods, the laboratory should also confirm that blank levels remain low enough to support the limit. Matrix-specific limits may differ when sample size, cleanup, dilution, or interference affects the achievable response.
Evaluate Calibration Performance
The calibration study should challenge the full proposed range. It must show acceptable fit without allowing the highest standards to dominate performance near the reporting limit.
Laboratories should assess:
- Number and distribution of calibration levels
- Back-calculated concentrations
- Weighting and regression model
- Response stability
- Continuing calibration performance
- Carryover after high standards
- Behaviour at the lowest level
These checks establish whether the calibration model supports routine quantitation across the claimed range.
Confirm Identification Criteria
A PFAS result requires evidence that the observed peak represents the target analyte. The validation or verification study should demonstrate acceptable retention-time stability, signal-to-noise ratio, and ion-ratio performance where a confirmation transition exists.
Linear and branched isomers require added attention. The chromatographic window must capture the isomer profile required by the method without including unrelated interference.
Some PFAS lack a reliable confirmation ion. For these compounds, the study should show that retention time, labelled-standard behaviour, blank control, and chromatographic separation provide sufficient selectivity.
Challenge Matrix Effects
Matrix effects can suppress or enhance electrospray response. The study should include representative samples from each matrix within scope and, where possible, variation within each category.
Wastewater from one source may behave differently from another. Soil can vary in organic content and particle composition. Tissue and food can introduce different lipid and protein burdens.
Labelled-standard recovery, matrix spikes, dilution studies, and post-extraction spikes can help locate the effect. The laboratory should determine whether isotope dilution corrects it or whether the workflow needs stronger cleanup, a smaller sample portion or a revised calibration strategy.
Assess Carryover and Contamination
PFAS can adsorb to surfaces or remain within the sample pathway after high-concentration samples. Carryover studies should challenge the system with concentrations that reflect the upper end of routine work, followed by blanks.
The study should cover the autosampler, LC system, and preparation equipment. If carryover appears, the laboratory must define additional washing, dilution, reinjection, or batch-order controls.
A method that performs well for clean fortified samples may still fail routine use if a high-level environmental sample affects everything analyzed after it.
Document Changes and Decisions
The final report should connect each claim to evidence. It should describe the method, equipment, analysts, standards, matrices, experimental design, results, deviations, and acceptance criteria.
The report should also state any limitations. A study completed in drinking water does not establish performance in wastewater. A validation covering 20 PFAS does not support an expanded list of 40 without additional evidence.
Method changes require documented review. A new column from the same general class may need a focused comparison, while a new extraction or matrix may require a broader validation.
Move From Study to Routine Control
Validation and verification provide a performance baseline. Routine quality control shows whether the laboratory continues to operate within it.
Control charts, blank trends, labelled-standard recoveries, calibration checks, and proficiency-testing results can reveal gradual changes that a single analytical batch may not expose.
The goal is not to produce a validation report that remains untouched. It is to establish a tested operating range and detect when the method moves outside it.
This article was produced under Separation Science's AI Editorial Guidelines.




